Angiotensin-(1-7)/Mas: novel therapeutic targets for treatment of pulmonary diseases
Online published: 2015-09-30
Supported by
National Natural Science Foundation of China, 81272145
Lung is a major site for the expression of angiotensin-converting enzyme (ACE) and generation of angiotensin Ⅱ (AngⅡ). Studies have showed that the renin-angiotensin system (RAS) involves in the pathogenesis of acute respiratory distress syndrome, pulmonary fibrosis, pulmonary hypertension, asthma, and lung cancer. There are two axes in the RAS, i.e. the ACE/AngⅡ/angiotensin Ⅱ type 1 receptor (AT1R) axis and the ACE2/angiotensin-(1-7) [Ang-(1-7)]/Mas axis. AngⅡ involves in the incidence and development of many pulmonary diseases through its specific receptor AT1R, while Ang-(1-7) counteracts the effect of AngⅡ via specific receptor Mas. This paper reviews the protective effect and possible molecular mechanisms of Ang-(1-7)/Mas during the course of several common pulmonary diseases.
Key words: angiotensin-(1-7); Mas; angiotensin Ⅱ; pulmonary disease
LIU Yu-jing , LI Ying-chuan . Angiotensin-(1-7)/Mas: novel therapeutic targets for treatment of pulmonary diseases[J]. Journal of Shanghai Jiao Tong University (Medical Science), 2015 , 35(9) : 1379 . DOI: 10.3969/j.issn.1674-8115.2015.09.027
/
〈 |
|
〉 |